EGFR exon 19 deletion is associated with favorable overall survival after first-line gefitinib therapy in advanced non–small cell lung cancer patients
YW Choi, SY Jeon, GS Jeong, HW Lee… - American journal of …, 2018 - journals.lww.com
Objectives: Exon 19 deletion and L858R mutation in exon 21 of the epidermal growth factor
receptor (EGFR) are both common mutations that predict a good response to EGFR tyrosine …
receptor (EGFR) are both common mutations that predict a good response to EGFR tyrosine …
EGFR Exon 19 Deletion is Associated With Favorable Overall Survival After First-line Gefitinib Therapy in Advanced Non-Small Cell Lung Cancer Patients
YW Choi, SY Jeon, GS Jeong… - … journal of clinical …, 2018 - pubmed.ncbi.nlm.nih.gov
Objectives Exon 19 deletion and L858R mutation in exon 21 of the epidermal growth factor
receptor (EGFR) are both common mutations that predict a good response to EGFR tyrosine …
receptor (EGFR) are both common mutations that predict a good response to EGFR tyrosine …
EGFR Exon 19 Deletion is Associated With Favorable Overall Survival After First-line Gefitinib Therapy in Advanced Non-Small Cell Lung Cancer Patients.
YW Choi, SY Jeon, GS Jeong, HW Lee… - American Journal of …, 2018 - europepmc.org
Objectives Exon 19 deletion and L858R mutation in exon 21 of the epidermal growth factor
receptor (EGFR) are both common mutations that predict a good response to EGFR tyrosine …
receptor (EGFR) are both common mutations that predict a good response to EGFR tyrosine …
EGFR Exon 19 Deletion is Associated With Favorable Overall Survival After First-line Gefitinib Therapy in Advanced Non–Small Cell Lung Cancer Patients
YW Choi, SY Jeon, GS Jeong, HW Lee… - American Journal of …, 2018 - ingentaconnect.com
Objectives: Exon 19 deletion and L858R mutation in exon 21 of the epidermal growth factor
receptor (EGFR) are both common mutations that predict a good response to EGFR tyrosine …
receptor (EGFR) are both common mutations that predict a good response to EGFR tyrosine …
[引用][C] EGFR Exon 19 Deletion is Associated with Favorable Overall Survival after First-line Gefitinib Therapy in Advanced Non-Small Cell Lung Cancer Patients
YW Choi, SY Jeon, GS Jeong, HW Lee… - American journal of …, 2018 - elibrary.ru
EGFR Exon 19 Deletion is Associated With Favorable Overall Survival After First-line Gefitinib Therapy in Advanced Non-Small Cell Lung Cancer Patients
YW Choi, SY Jeon, GS Jeong, HW Lee, SH Jeong… - repository.ajou.ac.kr
OBJECTIVES: Exon 19 deletion and L858R mutation in exon 21 of the epidermal growth
factor receptor (EGFR) are both common mutations that predict a good response to EGFR …
factor receptor (EGFR) are both common mutations that predict a good response to EGFR …